Dr. Lal PathLabs Share Price Surges 4%; Subsidiaries Approve Acquisitions in Ghana and Neuome Technologies

Written by: Team Angel OneUpdated on: 24 Jul 2026, 10:30 pm IST
Dr. Lal PathLabs' subsidiaries have approved acquisitions in Ghana and Neuome Technologies as part of the company's expansion strategy.
Dr. Lal PathLabs Share Price Surges
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Dr. Lal PathLabs Ltd. has informed the stock exchanges that the boards of its wholly-owned subsidiaries have approved two separate acquisitions. The proposed transactions involve the acquisition of a majority stake in Sunshine Healthcare Limited, Ghana, and a minority stake in Neuome Technologies Private Limited.  

Subsidiary to Acquire 80% Stake in Ghana-Based Diagnostics Firm 

The board of Dr. Lal PathLabs FZCO, Dubai, a wholly-owned subsidiary of the company, has approved the acquisition of an 80% equity stake in Sunshine Healthcare Limited (SHL), a diagnostics company based in Ghana. 

The acquisition will be carried out for a consideration of up to GHS 45.60 million.  

30% Stake Approved in Neuome Technologies 

Separately, the board of Dr. Lal Ventures Private Limited, another wholly-owned subsidiary, has approved the acquisition of a 30% equity stake in Neuome Technologies Private Limited. 

The proposed investment, valued at up to ₹3.5 crore, will be made through the subscription of equity shares. Neuome develops solutions in sample preservation, pre-analytical technologies and biobanking.  

Board Takes Note of Both Acquisitions 

Dr. Lal PathLabs said its Board of Directors took note of the approvals granted by the boards of its two wholly-owned subsidiaries during its meeting held on July 24, 2026. The company disclosed the developments under Regulation 30 of the SEBI Listing Regulations.  

Read More: Flipkart to Enter Food Delivery Business, Set to Challenge Zomato and Swiggy! 

Share Price Performance 

As of July 24 2026, Dr. Lal PathLabs share price closed at ₹1,759.20 per share, reflecting a surge of 4.27% from the previous trading session. 

Conclusion 

Dr. Lal PathLabs' wholly-owned subsidiaries have approved the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, and a 30% stake in Neuome Technologies Private Limited. The proposed transactions are subject to the terms disclosed by the company.  

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Published on: Jul 24, 2026, 5:00 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers